Literature DB >> 11093792

A tetratricopeptide repeat half-site in the aryl hydrocarbon receptor is important for DNA binding and trans-activation potential.

S L Levine1, J R Petrulis, A Dubil, G H Perdew.   

Abstract

Similar to certain unliganded steroid hormone receptor complexes, the unliganded aryl hydrocarbon receptor has been shown to consist of a multimeric core complex that includes the 90-kDa heat shock protein (hsp90) and the immunophilin-like hepatitis B X-associated protein 2 (XAP2). Immunophilins and XAP2 associated with these complexes bind to the carboxyl-terminal end of hsp90 through an interaction with their tetratricopeptide repeat (TPR) domains. The consensus TPR binding motif contains two domains, A and B. Recently, the carboxyl terminus of XAP2 has been shown to contain a highly conserved TPR domain that is required for the assembly of XAP2 with both hsp90 and AhR. A search of the murine AhR sequence identified domain B (A-F-A-P) of the consensus TPR sequence directly adjacent to the carboxyl-terminal side of the helix-loop-helix region of the murine and human AhR. We hypothesized that this conserved domain B region may be involved with mediating interactions between either AhR-hsp90, AhR-XAP2, and/or AhR-AhR nuclear translocator protein. Site-directed mutagenesis of the amino-terminal alanine residue of this region to an aspartic acid (A78D) completely inhibited 2,3,7, 8-tetrachloro-p-dioxin (TCDD) -dependent activation of a xenobiotic response element (XRE) driven gene expression construct in transfected COS-1 and BP8 cells. The A82F mutation caused a 40 to 50% decrease in TCDD-dependent activation. The inability of A78D and the reduction of A82F to trans-activate XRE-driven reporter activity did not result from impaired AhR-XAP2-hsp90 interactions, TCDD-dependent AhR translocation to the nucleus, or AhR-AhR nuclear translocator protein interactions. In vitro DNA binding analysis demonstrated that loss of trans-activation potential by the A78D mutation resulted from impaired XRE binding. This study underscores the potential importance of AhR mutations that occur naturally outside of known functional domains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093792     DOI: 10.1124/mol.58.6.1517

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

1.  Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner.

Authors:  Rachel Tanos; Rushang D Patel; Iain A Murray; Philip B Smith; Andrew D Patterson; Gary H Perdew
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

2.  Role of arginine residues 14 and 15 in dictating DNA binding stability and transactivation of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator heterodimer.

Authors:  Susanne C Wache; Erica M Hoagland; Georgia Zeigler; Hollie I Swanson
Journal:  Gene Expr       Date:  2005

3.  Structural modeling of the AhR:ARNT complex in the bHLH-PASA-PASB region elucidates the key determinants of dimerization.

Authors:  Dario Corrada; Michael S Denison; Laura Bonati
Journal:  Mol Biosyst       Date:  2017-05-02

Review 4.  The Ah Receptor: Adaptive Metabolism, Ligand Diversity, and the Xenokine Model.

Authors:  Mele N Avilla; Kristen M C Malecki; Mark E Hahn; Rachel H Wilson; Christopher A Bradfield
Journal:  Chem Res Toxicol       Date:  2020-04-07       Impact factor: 3.739

5.  Ah receptor represses acute-phase response gene expression without binding to its cognate response element.

Authors:  Rushang D Patel; Iain A Murray; Colin A Flaveny; Ann Kusnadi; Gary H Perdew
Journal:  Lab Invest       Date:  2009-03-30       Impact factor: 5.662

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.